Neuromuscular junction

14 September 2022
14-PM-Parallel-1 16:30 > 18:00 Neuromuscular junction Apollon Auditorium

16:30 S13L1 New treatments for autoimmune myasthenia gravis > E. Emilien DELMONT 17:00 S13L2 Use of human pluripotent stem cells for Neuromuscular Disorders > C. Cecile MARTINAT 17:30 S13L3 Targeting the neuromuscular junction (NMJ) to treat congenital myasthenic syndromes and inherited motor neuropathies with NMJ dysfunction > S. Sally SPENDIFF
Copyright © key4events - All rights reserved